Senseonics Holdings (SENS) Free Cash Flow Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -1.82% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 226.77% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 9.73% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -51.69% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -109.40% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 133.09% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 363.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 108.16% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 29.12% |
| 10 | Senseonics Holdings | 316.18 Mn | 251.85 Mn | 6.94 Mn | -94.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -94.60% |
| Dec 31, 2025 | -38.83% |
| Sep 30, 2025 | -12.82% |
| Jun 30, 2025 | 32.85% |
| Mar 31, 2025 | 19.75% |
| Dec 31, 2024 | 17.27% |
| Sep 30, 2024 | 15.96% |
| Jun 30, 2024 | 26.45% |
| Mar 31, 2024 | -3.43% |
| Dec 31, 2023 | 13.67% |
| Sep 30, 2023 | -18.86% |
| Jun 30, 2023 | -26.21% |
| Mar 31, 2023 | 1.97% |
| Dec 31, 2022 | -48.36% |
| Sep 30, 2022 | -5.27% |
| Jun 30, 2022 | -0.50% |
| Mar 31, 2022 | -24.75% |
| Dec 31, 2021 | -42.56% |
| Sep 30, 2021 | -2.49% |
| Jun 30, 2021 | 15.06% |
| Mar 31, 2021 | 44.09% |
| Dec 31, 2020 | 75.48% |
| Sep 30, 2020 | 62.77% |
| Jun 30, 2020 | 52.93% |
| Mar 31, 2020 | 4.74% |
| Dec 31, 2019 | -45.20% |
| Sep 30, 2019 | -33.69% |
| Jun 30, 2019 | -77.13% |
| Mar 31, 2019 | -48.91% |
| Dec 31, 2018 | -41.82% |
| Sep 30, 2018 | -77.44% |
| Jun 30, 2018 | -57.07% |
| Mar 31, 2018 | -76.16% |
| Dec 31, 2017 | -59.45% |
| Sep 30, 2017 | -46.05% |
| Jun 30, 2017 | -24.15% |
| Mar 31, 2017 | -55.94% |
| Sep 30, 2016 | -7,911.34% |
| Jun 30, 2016 | 3.19% |
| Mar 31, 2016 | -48.36% |
| Sep 30, 2015 | -2,250.64% |